Product Portfolio Expansion with New Cystic Fibrosis Treatment Project
Profarma is expanding its innovative product portfolio with the launch of a project aimed at developing advanced pharmaceutical forms and technologies for treating cystic fibrosis. Supported by funding from the European Union, this initiative marks a significant step forward in enhancing treatment options for cystic fibrosis patients worldwide. New Pharmaceutical Forms of Ivacaftor: As part […]